Skip to content

Public FDA record

Z-3040-2011: enFlow IV Fluid Warmer Part number 980105VS; (510K name: enFlow IV Fluid Warmer Model 100, EFlow Disposab

Recall record Z-3040-2011 for Vital Signs Devices, a GE Healthcare Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3040-2011
Company in FDA record
Vital Signs Devices, a GE Healthcare Company
FDA classification date
Aug 19, 2011
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

enFlow IV Fluid Warmer may have an issue which results in excessive external surface temperature on the underside of the warmer.

Source facts

Action
GE Healthcare sent UMDC Letters/UMDC Confirmation Letters to customers on June 30, 2011. GE Healthcare sent UMDC Letters/UMDC Confirmation Letters on October 24, 2011 reflecting a new recall strategy.
Initiated
2011-06-30
Root cause
Device Design
Terminated
2013-06-14
Distribution
Worldwide Distribution - USA (nationwide) and the country of Vietnam
Recall number
Z-3040-2011
Recall status
Terminated
CDRH record ID
103330
FDA classified
2011-08-19
Recall event number
59688

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗